Healthcare Brand Receives INR 5 Crore in Seed Funding

Health care startup

Acculi Labs, a Bengaluru-based health diagnostic company has announced that it had raised INR 5 crore (about $700,000) in a seed round from PirE Ventures. PirE Ventures is an investment firm based out of Mumbai and was started by Rupam Das in May 2017.

The aim of Acculi Labs is to make home-based care available even to the last person at the bottom of the pyramid. Lyfas is its flagship product. It enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients even in the remotest part of the world. It also helps them to approach their doctor at an early stage.

CTO and CEO of Acculi Labs, Rupam Das said,”The investment will be used to bring our to reality. [Our] R&D will work with new vigour and rigour to simplify healthcare for the needy. [We] will run full operations to ensure that Lyfas becomes the need of every household, irrespective of geophysical location, as we at Acculi believe that healthcare is the need of people.”

Geetha Mahadevappa from PirE Ventures said, “We see a lot of potential in Lyfas to transform the way we diagnose and monitor diseases today. The asset-light and tech-driven models of the company are easily pluggable into various setups, including OPD, telemedicine, and post-surgery care. We believe that together PirE and Acculi can redefine digital health not only for people, but for the nation”.

In September 2019, Acculi Labs had received undisclosed pre-seed from a group of angels and Bengaluru-based consultancy and services firm named Basket. It had also received under the Idea2PoC scheme, under the Startup Karnataka policy. It was also selected as one of the top startups of ELEVATE 2018, an initiative of the Department of Information and Biotechnology, Government of Karnataka.


Please enter your comment!
Please enter your name here